Nymox Pharmaceutical Corp
(NASDAQ : NYMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.90%96.890.6%$494.49m
ABTAbbott Laboratories
1.12%68.430.8%$296.21m
ISRGIntuitive Surgical, Inc.
1.14%564.992.4%$255.40m
TMOThermo Fisher Scientific Inc.
0.35%239.301.0%$245.21m
ALGNAlign Technology, Inc.
2.10%386.326.3%$230.79m
BAXBaxter International Inc.
0.51%77.441.7%$209.34m
BSXBoston Scientific Corporation
0.40%37.421.1%$206.07m
BDXBecton, Dickinson and Company
1.02%259.841.1%$205.74m
SYKStryker Corporation
1.34%172.161.3%$171.59m
ABMDABIOMED, Inc.
1.70%375.173.3%$168.49m
TNDMTandem Diabetes Care, Inc.
-3.33%38.844.1%$137.75m
EWEdwards Lifesciences Corporation
-0.08%146.181.2%$133.24m
DXCMDexCom, Inc.
1.42%139.898.5%$128.68m
ZBHZimmer Biomet Holdings, Inc.
0.88%130.691.7%$127.78m
XRAYDENTSPLY International Inc.
0.01%38.113.0%$104.01m

Company Profile

Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.